165 related articles for article (PubMed ID: 25116129)
1. Neurocognitive moderation of associations between cannabis use and psychoneuroticism.
Huijbregts SC; Griffith-Lendering MF; Vollebergh WA; Swaab H
J Clin Exp Neuropsychol; 2014; 36(8):794-805. PubMed ID: 25116129
[TBL] [Abstract][Full Text] [Related]
2. Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypy.
Lee SY; Bang M; Kim KR; Lee MK; Park JY; Song YY; Kang JI; Lee E; An SK
Schizophr Res; 2015 Jun; 165(1):60-5. PubMed ID: 25864951
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
[TBL] [Abstract][Full Text] [Related]
4. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
[TBL] [Abstract][Full Text] [Related]
5. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
6. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.
Rabin RA; Zakzanis KK; George TP
Schizophr Res; 2011 May; 128(1-3):111-6. PubMed ID: 21420282
[TBL] [Abstract][Full Text] [Related]
7. Emotion recognition in psychosis: no evidence for an association with real world social functioning.
Janssens M; Lataster T; Simons CJ; Oorschot M; Lardinois M; van Os J; Myin-Germeys I;
Schizophr Res; 2012 Dec; 142(1-3):116-21. PubMed ID: 23122740
[TBL] [Abstract][Full Text] [Related]
8. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
Arnold C; Allott K; Farhall J; Killackey E; Cotton S
Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
[TBL] [Abstract][Full Text] [Related]
10. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
11. Understanding facial emotion perception in Parkinson's disease: the role of configural processing.
Narme P; Bonnet AM; Dubois B; Chaby L
Neuropsychologia; 2011 Oct; 49(12):3295-302. PubMed ID: 21856319
[TBL] [Abstract][Full Text] [Related]
12. Misreading the facial signs: specific impairments and error patterns in recognition of facial emotions with negative valence in borderline personality disorder.
Unoka Z; Fogd D; Füzy M; Csukly G
Psychiatry Res; 2011 Oct; 189(3):419-25. PubMed ID: 21429593
[TBL] [Abstract][Full Text] [Related]
13. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
14. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
15. Impaired recognition of happy, sad and neutral expressions in schizophrenia is emotion, but not valence, specific and context dependent.
Silver H; Bilker W; Goodman C
Psychiatry Res; 2009 Sep; 169(2):101-6. PubMed ID: 19692127
[TBL] [Abstract][Full Text] [Related]
16. Cannabis use before age 15 and subsequent executive functioning.
Fontes MA; Bolla KI; Cunha PJ; Almeida PP; Jungerman F; Laranjeira RR; Bressan RA; Lacerda AL
Br J Psychiatry; 2011 Jun; 198(6):442-7. PubMed ID: 21628706
[TBL] [Abstract][Full Text] [Related]
17. Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders.
Narme P; Mouras H; Roussel M; Duru C; Krystkowiak P; Godefroy O
Neuropsychology; 2013 Mar; 27(2):182-92. PubMed ID: 23527646
[TBL] [Abstract][Full Text] [Related]
18. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study.
Griffith-Lendering MF; Wigman JT; Prince van Leeuwen A; Huijbregts SC; Huizink AC; Ormel J; Verhulst FC; van Os J; Swaab H; Vollebergh WA
Addiction; 2013 Apr; 108(4):733-40. PubMed ID: 23216690
[TBL] [Abstract][Full Text] [Related]
20. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
